Irani et al. [17] demonstrated that AT1-AAs may contribute to intrauterine growth restriction (IUGR) through a direct detrimental effect by activating AT1 receptors on multiple fetal organs, and indirectly by inducing small placentas characterized by increased trophoblast apoptosis. The gene discussed is AGTR1; the disease is fetal growth restriction.